embecta sponsors educational symposium at ATTD 2023
<!-- Name:DistributionId Value:8754813 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
embecta
Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial…
embecta Announces Earnings Conference Call Information for the Third Quarter of…
PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1,…
embecta to Participate in Upcoming Investor Conferences in May
PARSIPPANY, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:…
embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes…
100-year legacy in insulin delivery Largest producer of diabetes injection devices in the world Over 2,000 employees globally serving more than 100 countries. FRANKLIN LAKES, N.J.,…